Abstract
The field of genetic toxicology finds itself at a crossroads. On the one hand, the premise of the somatic mutation theory of cancer, which provides a scientific basis for the development of short-term tests for predicting cancers, has been amply vindicated by the discovery of oncogene activation. On the other hand, however, recent NTP-sponsored studies have cast doubt upon the performance of short-term tests as predictors of carcinogenicity (Tennant et al., 1987). Analysis of the NTP results by the CPBS shows that this is an incorrect conclusion resulting from an oversimplification (Rosenkranz and Ennever, 1988a). Also, it appears that we have no choice but to continue using short-term tests since the other alternatives are (a) not to test but to wait for untoward effects in our exposed human population and (b) to continue relying solely on animal bioassays.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ashby, J., 1986, “The prospects for a simplified and internationally harmonized approach to the detection of possible human carcinogens and mutagens,” Mutagenesis, 1:3–16.
Chankong, V., Haimes, Y. Y., Rosenkranz, H. S., and Pet-Edwards, J., 1985, “The Carcinogenicity Prediction and Battery Selection (CPBS) method: A Bayesian approach,” Mutation Res. 153:135–166.
Dearfield, K. L., Abnerathy, C. O., Ottley, M. S., Brantner, J. H., and Hayes, P. F., 1988, “Acrylamide: Its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity,” Mutation Res., 195:45–47.
Ennever, F. K., and Rosenkranz, H. S., 1986a, “Predicting the carcinogenicity of the aromatic amine derivatives tested in the second UKEMS Collaborative Study,” Mutagenesis, 1:119–123.
Ennever, F. K., and Rosenkranz, H. S., 1986b, “Short-term test results for NTP noncarcinogenesis: An alternate, more predictive battery,” Environ. Mutagenesis, 8:849–865.
Ennever, F. K., and Rosenkranz, H. S., 1986c, “Evaluating batteries of short-term genotoxicity tests,” Mutagenesis, 1:293–298.
Ennever, F. K., and Rosenkranz, H. S., 1987a, “Evaluating the potential genotoxic carcinogenicity of methyl isocyanate,” Toxical. Appl. Pharmacol., 91:502–505.
Ennever, F. K., and Rosenkranz, H. S., 1987b, “Selection of batteries in an industrial setting,” Environ. Mutagenesis, 9:359–361.
Ennever, F. K., and Rosenkranz, H. S., 1988a, “The influence of the proportions of carcinogens on the cost-effectiveness of short-term tests,” Mutation Res., 197:1–13.
Ennever, F. K., and Rosenkranz, H. S., 1988b, “Methodologies for interpretations of short-term test results which may allow reduction in the use of animals in carcinogenicity testing,” Toxicol. Ind. Health, 4:137–149.
Ennever, F. K., Noonan, T. J., and Rosenkranz, H. S., 1987, “The predictivity of animal bioassays and short-term genotoxicity test for carcinogenicity and noncarcinogenicity to humans,” Mutagenesis, 2:73–78.
Gold, L. S., de Veciana, M., Backman, G. M., Magaw, R., Lopipero, Pl., Smith, M., Hooper, N. K., Havender, W. R., Bernstein, L., Peto, R., Pike, M. C., and Ames, B. N., 1984, “A carcinogenic potency database of the standardized results of animal bioassays,” Environ. Health Perspect., 58:9–319.
Griesemer, R. A., Harper, C., Calabrese, E., Michalopoulos, G., Rosenkranz, H. S., Schneider-man, M., and Sipes, I. G., 1985, “Report to the U.S. Consumer Product Safety Commission by the Chronic Hazard Advisory Panel on Di-(2-Ethylhexyl)phthalate.
Haimes, Y. Y., Chankong, V., Pet-Edwards, J., and Rosenkranz, H. S., 1987, “Carcinogenicity prediction and battery selection procedure: An in depth analysis of cyclamate and its major metabolite cyclohexylamine,” Molec. Toxicol., 1:49–60.
Havel, R. J., Griesemer, R. A., Lagakos, S. W., Munro, I. C., Pitot, H. C., Rosenkranz, H. S., Stellman, S., Tardiff, R. G., Thomas, D. W., Ward, J. N., Weinhouse, S., and Williams G. M., 1985, Evaluation of Cyclamates for Carcinogenicity, National Academy of Sciences Press, Washington D.C.
Hu, S., 1985, “A multiobjective risk methodology for the optimal selection of a battery of tests,” M.S. thesis, Case Western Reserve, University.
IARC, 1986, “IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humains, Some Chemicals Used in Plastics and Elastomers,” Vol. 39, pp. 41–66, International Agency for Research on Cancer, Lyon, France.
IARC, 1988, “IARC Monograph Supplement 7,” International Agency for Research on Cancer, Lyon, France.
Jerina, D. M., Lehr, R. E., Yagi, H., Hernandez, O., Dansette, P. M., Wislocki, P. G., Wood, A. W., Chang, R. L., Levin, W., and Conney, A. H., 1976, “Mutagenicity of benzo(a)pyrene derivatives and the description of a quantum mechanical model which predicts the ease of carbonium ion formation from diol epoxides,” in F. J. de Serres, J. R. Fouts, J. R. Bend, and R. M. Philpot (eds.): In Vitro Metabolic Activation in Mutagenesis Testing, Elsevier/North-Holland Biomedical Press, Amsterdam, pp. 159–178.
Lave, L. B., Ennever, F. K., Rosenkranz, H. S., and Omenn, G. S., 1988, “Information value of the rodent bioassay,” Nature, 336:631–633.
Matsushima, T., 1987, Chemical Safety Evaluation in Japan, 175.
Miller, J. A., 1970, “Carcinogenesis by chemicals: An overview,” Cancer Res., 30:559–576.
Miller, J. A., and Miller, E. C., 1977, “Ultimate chemical carcinogens as reactive mutagenic electrophiles,” in Origins of Human Cancer, H. H. Hiatt, J. D. Watson, and J. A. Winsten (eds.), Cold Spring Harbor Laboratory: Cold Spring Harbor, pp. 605–627.
Nesnow, S., Argus, M., Bergman, H., Chu, K., Frith, C., Helmes, T., McGaughey, R., Ray, V., Slaga, T. J., Tennant, R., and Weisburger, E., 1987, “Chemical carcinogens: A review and analysis of the literature of selected chemicals and the establishment of the Gene-Tox Carcinogen Data Base,” Mutation Res., 185:1–195.
Paladja, M., and Rosenkranz, H. S., 1985, “Assembly and preliminary analysis of a genotoxicity data base for predicting carcinogens,” Mutation Res., 153:79–134.
Pet-Edwards, J., 1986, “Selection and interpretation of conditionally independent tests for binary predictions: A Bayesian approach,” Ph.D. dissertation, Case Western Reserve University, Cleveland, Ohio.
Pet-Edwards, J., Chankong, V., Rosenkranz, H. S., and Haimes, Y. Y., 1985a, “Application of the carcinogenicity prediction and battery selection (CPBS) methodology to the Gene-Tox data base,” Mutation Res., 153:187–200.
Pet-Edwards, J., Rosenkranz, H. S., Chankong, V., and Haimes, Y. Y., 1985b, “Cluster analysis in predicting the carcinogenicity of chemicals using short-term assays,” Mutation Res., 153:167–185.
Rosenkranz, H. S., and Ennever, F. K., 1987, “Evaluation of the genotoxicity of theobromine and caffeine,” Food Chem. Toxicol., 25:247–251.
Rosenkranz, H. S., and Ennever, F. K., 1988a, “New approaches to battery selection and interpretation,” in: New Trends in Genetic Toxicology, G. Jolies and A. Cordier (eds.), Academic Press, New York, in press.
Rosenkranz, H. S., and Ennever, F. K., 1988b, “Quantifying genotoxicity and nongenotoxicity,” Mutation Res., 205:59–67.
Rosenkranz, H. S., and Klopman, G., 1987, “Computer automated structure evaluation of the carcinogenicity of N-nitrosothiazolidine 4-carboxylic acid,” Chem. Toxicol., 25:253–256.
Rosenkranz, H. S., Ennever, F. K., Chankong, V., Pet-Edwards, J., and Haimes, Y. Y., 1986a, “An objective approach to the deployment of short-term tests predictive of carcinogenicity,” Cell Biol. Toxicol., 2:425–440.
Rosenkranz, H. S., Frierson, M. R., and Klopman, G., 1986b, “Computer-automated prediction of the mutagenicity of benzidine, 4,4″-diaminoterphenyl, 4-dimethylaminoazobenzene and 4-cyanodimethylaniline: Comparison with the results of the Second UKEMS Collaborative Study,” Mutagenesis, 1:275–282.
Rosenkranz, H. S., Frierson, M. R., and Klopman, G., 1988, “Predicting the carcinogenicity of pyrene, benzo(a)pyrene, 2-acetylaminofluorene and 4-acetylaminofluorene using newly developed computer based methods,” in: Evaluation of Short-Term Tests for Carcinogens, Report of the International Programme on Chemical Safety’s Collaborative Study on in vivo Assays, J. Ashby, et al. (eds.), Cambridge University Press, in press.
Tennant, R. W., Margolin, B. H., Shelby, M. D., Zeiger, E., Haseman, J. K., Spalding, J., Caspary, W., Resnick, M., Stasiewicz, S., Anderson, B., and Minor, R., 1987, “Prediction of chemical carcinogenicity in rodents from in vitro genotoxicity assays,” Science, 236:933–941.
Weisburger, J. H., and Williams, G. M., 1981, “Carcinogen testing: Current problems and new approaches,” Science, 214:401–407.
Yander, G., Lin, G. H. Y., and Mermelstein, R., 1987, “Selection of batteries in an industrial setting (Letter to the Editor),” Environ. Mutagenesis, 9:357–358.
Zeiger, E., 1987, “Carcinogenicity of mutagens: Predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity,” Cancer Res., 47:1287–1296.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Pet-Edwards, J., Haimes, Y.Y., Chankong, V., Rosenkranz, H.S., Ennever, F.K. (1989). Applications of CPBS to Cancer Hazard Identification. In: Risk Assessment and Decision Making Using Test Results. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5595-3_6
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5595-3_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5597-7
Online ISBN: 978-1-4684-5595-3
eBook Packages: Springer Book Archive